Male/female adults
Conditions
Interventions
The device is applied to the parotid gland area for 15 minutes.
Sponsors
Crane Science Corp.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male and female aged 50 to below 70 years at the time of consent acquisition. 2. Individuals with a saliva volume of 2 to 6 grams at the time of baseline assessment. 3. Individuals who are able to give informed consent to participate in this study after receiving a detailed explanation of the protocol and understanding its contents.
Exclusion criteria
Exclusion criteria: 1. Individuals who regularly use products that could affect the study (such as Food for Specified Health Uses, Foods with Function Claims including reduced coenzyme Q10, or health foods including supplements) more than three times a week and cannot discontinue their use from the time of consent. 2. Individuals who are taking medications (such as antihistamines, antidepressants, or antihypertensives) that might affect the study and cannot limit their use during the study period. 3. Individuals with excessive alcohol intake. 4. Individuals with previous and/or current medical history of serious diseases in the heart, liver, kidney, digestive organs, oral cavity. 5. Individuals with sensory skin disorders, skin abnormalities, susceptibility to Low-temperature burn. 6. Individuals using implantable medical devices such as pacemakers or implantable cardioverter-defibrillators that may be susceptible to electromagnetic interference. 7. Individuals who are participating in, have participated in within the four weeks prior to the current trial, or are planning to participate in clinical trials of pharmaceuticals or health foods. 8. Females who are pregnant or lactating, and those who intend to become pregnant during the trial period. 9. Individuals deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Saliva volume | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective questionnaire | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed